Sign in

Chris Hopkins

@chrishopkins123.bsky.social
20 followers 39 following 27 posts

ID & Acute Medicine Physician at Middlemore Hospital, Auckland, NZ

PostsRepliesMedia
Chris Hopkins @chrishopkins123.bsky.social · 08/09/2026
Really happy to finally get this published! This is a qualitative study on front-line clinicians' rationale for sending urine cultures. The 4 themes we identified are summarised in the diagram. #UTIsky www.cambridge.org/core/journal...
cambridge.org
Changing the culture: a qualitative study on clinicians’ rationale for requesting urine cultures | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Changing the culture: a qualitative study on clinicians’ rationale for requesting urine cultures - Volume 6 Issue 1
252
Chris Hopkins @chrishopkins123.bsky.social · 28/08/2026
My hospital in South Auckland is advertising for Acute Medicine Consultants. This is half of my job - so come and join me in Auckland NZ! It's a really rewarding, challenging job and a great place to live. Advert in BMJ Careers: www.bmj.com/careers/job/... #acutemedicine
bmj.com
Senior Medical Officer, General Medicine - Acute Medicine - Auckland (Region) (NZ) job with Health New Zealand | 842909
We're seeking Acute Medicine Senior Medical Officers with a passion for Acute Medicine to join our team in Auckland, New Zealand.
000
Reposted by Chris Hopkins
Open Forum Infectious Diseases @ofidjournal.bsky.social · 18/08/2026
Management, Outcomes, and Factors Associated with Mortality and Treatment Failure of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand ✅ Just Accepted ⭐ Editor's Choice 🔗 bit.ly/3U3n1XF
122
Chris Hopkins @chrishopkins123.bsky.social · 03/07/2026
Who exactly still needs antivirals for COVID? An Aussie/Kiwi take on it... TL:DR - in 2026 it's hard to define the tiny group who may benefit in the absence of good data. #IDsky #AMSsky onlinelibrary.wiley.com/doi/10.5694/...
onlinelibrary.wiley.com
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild‐to‐Moderate COVID‐19 Cases in a Broadly Immune Population
Antivirals for mild-to-moderate coronavirus disease 2019 (COVID-19) were adopted for use based on trials in unvaccinated adults during the pre-Omicron period. In today's broadly immune populations, w....
020
Reposted by Chris Hopkins
NEJM.org @nejm.org · 19/06/2026
Although best practices are established for managing 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 bacteremia, the preferred antibiotic for methicillin-susceptible 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴 bacteremia is uncertain. Research findings from the SNAP trial are summarized in a new Quick Take video. nej.md/4uBjkVL
Illustration showing three vials labeled cefazolin, flucloxacillin, and cloxacillin. The words "vs." and "OR" are between them. A silhouette stands to the right, with Staphylococcus aureus bacteremia in the background.
0104
Reposted by Chris Hopkins
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 06/05/2026
Static vs. cidal: it’s not complex; it’s simply incorrect @bradspellberg.bsky.social et Al Honored to be part of this amazing group who challenges dogmas and debunk ID myths #idsky #microsky journals.asm.org/doi/10.1128/...
2136
Reposted by Chris Hopkins
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 22/04/2026
Finally published 🆕🔥PANORAMIC RCT + CanTreatCOVID Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients Paxlovid did not reduce the incidence of hospitalization or death among vaccinated higher-risk participants with SARS-CoV-2 infection #idsky www.nejm.org/doi/full/10....
2135
Reposted by Chris Hopkins
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 21/04/2026
🔥 Late Breakers SNAP platform RCT| Adjunctive Clindamycin in S.aureus bacteraemia ❌ No mortality benefit 90d mortality:16.9% vs 15.2% aOR 1.16 (CrI cross 1) 📊PPSup(~7%)→Futility threshold reached ⚠️ICU subgp:numerically worse with clinda ⚖️CDAD:no # (~2%)😯 #ESCMIDGlobal2026 #idsky
1239
Reposted by Chris Hopkins
NEJM.org @nejm.org · 14/04/2026
Our latest video in our partnership with @glaucomflecken.bsky.social summarizes a trial evaluating the clinical efficacy of tecovirimat against human clade II mpox. Read the full study for free: nej.md/DrG38
0142
Reposted by Chris Hopkins
Gabriele Pollara @gpollara.bsky.social · 06/04/2026
"Among 5121 participants assessed, 1573 (30.7%) underwent DOC, of which 1502 (95.5%) were delabeled." - that's a lot of penicillin allergy mislabelling out there! 😲 However... DOC.. more likely to be prescribed penicillin and less likely WHO “Watch” or “Reserve” antibiotics #IDSky #ClinMicro #AMR
academic.oup.com
Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) Study
Abstract. In this international, multicenter prospective study, implementing penicillin direct oral challenge (DOC) using a digital toolkit was acceptable,
081
Chris Hopkins @chrishopkins123.bsky.social · 23/03/2026
NZ now has national antibiotic guidelines - Te Whata Kura! 💊 This supports consistent, rational antibiotic prescribing across primary and secondary care across Aotearoa NZ. Supports access from mobile devices. Link: tewhatakura.nz Funded by a grant from Te Niwha platform #AMSsky #IDsky
021